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I am pleased to be in the position of introducing
the 10th volume of Clinical Microbiology and
Infection. CMI was first published in September
1995 under the leadership of Jacques Acar, Ian
Phillips and David Speller, who guided and
established the journal during its early years with
great care and distinction. Since June 2000, Emilio
Bouza and his editorial team in Madrid have
worked diligently and successfully to improve
and expand the quality and diversity of material
published in CMI. The journal is now receiving
unprecedented numbers of submissions, we have
an impact factor comparable with other journals
in our field and, according to a recent poll,
ESCMID members consider that their subscrip-
tion to CMI is one of the most important and
valuable components of their membership. Now,
as the journal enters Volume 10, it is a great
personal honour to be asked to take up the
challenge of leading CMI to the next level for the
mutual benefit of our authors and the scientific
community.
Regular readers will already have noticed a
number of stylistic changes to the journal, not
least the new cover design. Internally, there are
also some changes in format and style, most of
which are designed to save space. Further details
can be found in our updated ‘Guidelines for
Authors’. CMI remains a journal that does not
impose page charges, and we are therefore lim-
ited in the number of pages that we can publish
each month. A problem resulting from the recent
popularity of CMI with authors has been the
increasing number of accepted papers, leading to
corresponding delays in publication. By saving
space, we hope to publish more papers each
month and reduce the delays to a minimal level.
We now have a ‘fast-track’ process for topical
papers of the highest quality, which should
lead to publication within 3 months of accept-
ance. In addition, with the ready collaboration of
our publishers, Blackwell Publishing, we will
shortly be introducing a system of ‘on-line early’
publication in which all accepted papers will be
published in a citable format on the internet as
soon as they reach the corrected proofs stage. In
this way, authors will see their work made
available to the scientific community at the
earliest possible opportunity, with publication in
the conventional printed form to follow later.
The editorial process has also undergone some
modifications. I am very grateful to have the
support of an active and enthusiastic team of
editors to assist with evaluating the continuously
increasing flow of manuscripts, and some of you
will already have experienced our new on-line
manuscript submission system and been in con-
tact with members of the new editorial team. It is
clear that manuscripts are passing much more
quickly through the system, and hopefully the
electronic experience will prove a pleasant and
efficient one for authors, editors and reviewers.
The final stages in the scientific editorial process
are the responsibility of Katrina Levi and myself
in Nottingham, while Judith Crane remains as
Managing Editor in Paris in overall charge of
dealings with our publisher. Carl Erik Nord in
Stockholm, in conjunction with the Paris office,
has assumed responsibility for all CMI supple-
ments.
The immediate ambition of the editorial team is
to make CMI the foremost European journal for
clinical microbiology and infectious diseases.
However, to achieve this goal, we will need the
continued support of our readers, both as authors
and reviewers of the submissions that we receive.
I hope that we can rely on your support and that
you will consider CMI to be a suitable journal for
publishing some of your best work. We look
forward to receiving your submissions and feed-
back, and thank you in anticipation of your
collaboration in the ongoing review process.
Kevin Towner
Editor-in-Chief
Nottingham, UK
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